References
- Nakagawa M, Sekijima Y, Yazaki M, et al. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23(1):58–63. doi:10.3109/13506129.2015.1135792.
- Godara A, Riesenburger RI, Zhang DX, et al. Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid. 2021;28(4):226–233. doi:10.1080/13506129.2021.1950681.
- Snyder ME, Haidar GR, Spencer B, et al. Transthyretin cardiac amyloidosis diagnosed by analyzing a prostatic tissue sample: a case report. J Am Geriatr Soc. 2011;59(9):1745–1747. doi:10.1111/j.1532-5415.2011.03549.x.
- Wilson SK, Buchanan RD, Stone WJ, et al. Amyloid deposition in the prostate. J Urol. 1973;110(3):322–323. doi:10.1016/S0022-5347(17)60202-7.
- Foix MP, Calvo DF, Condom I Mundó E, et al. Clinical relevance of amyloid in prostate samples: a report on 40 patients. Histopathology. 2022;81(3):363–370. doi:10.1111/HIS.14717.
- Dasari S, Dispenzieri A, Mansour S, et al. Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis. ESC Heart Fail. 2021;8(1):750–755. doi:10.1002/EHF2.13130.
- Nevo A, Muchtar E, Stern KL, et al. The clinical implication of incidental prostatic amyloidosis. Urology. 2020;145:253–257. doi:10.1016/j.urology.2020.08.053.
- Tasaki M, Misumi Y, Nomura T, et al. Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis. Amyloid. 2022;29(4):278–280. doi:10.1080/13506129.2022.2101920.